Telehealth application of an ultrasonic home spirometer
Authors:
- 11 March 2022
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 107 (8) , 752-754
Abstract
Objective: To investigate the validity and home use of a personal ultrasonic spirometer.Methods: Supervised spirometry was performed using laboratory equipment and a personal ultrasonic spirometer. In addition, the ability of children to perform acceptable spirometry during supervised telehealth appointments at home was assessed.Results: 59 children completed spirometry on both devices. There was high between-device intraclass correlation coefficient (ICC) for forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC): ICC 0.991 (95% CI 0.985 to 0.995) and 0.989 (95% CI 0.981 to 0.993), respectively. Bland-Altman analysis revealed mean bias and limits of agreement of −0.01 (−0.22 to 0.24) L for FEV1and −0.02 (−0.30 to 0.33) L for FVC. 125 of 140 (89%) supervised telehealth spirometry sessions were acceptable.Conclusion: There was excellent reliability in between-device measurements; however, the limits of agreement were wide. Therefore, caution is needed if the device is used interchangeably with laboratory equipment. High success rates of telehealth spirometry sessions indicate the device is suitable for this application.Keywords
Funding Information
- HCF Research Foundation (201903550148)
- The Sydney Children's Hospitals Network Foundation
This publication has 5 references indexed in Scilit:
- Technical validity and usability of a novel smartphone‐connected spirometry device for pediatric patients with asthma and cystic fibrosisPediatric Pulmonology, 2020
- Telehealth transformation: COVID-19 and the rise of virtual careJournal of the American Medical Informatics Association, 2020
- Comparison of a handheld turbine spirometer to conventional spirometry in children with cystic fibrosisPediatric Pulmonology, 2020
- Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical StatementAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Early anti-pseudomonal acquisition in young patients with cystic fibrosis: Rationale and design of the EPIC clinical trial and observational study,Contemporary Clinical Trials, 2009